CERT
- Certara, Inc.
()
Overview
Company Summary
Certara, Inc. is a leading global company specializing in providing scientific software and consulting services to aid in drug development and regulatory decision-making. Established in 2008, Certara focuses on assisting pharmaceutical, biotechnology, and healthcare organizations to optimize drug development and improve patient outcomes.
Certara offers a range of software solutions that help scientists and researchers develop safer and more effective drugs. Some of their flagship software products include Phoenix, Simcyp, Trial Simulator, D360, and PKS. These applications integrate large datasets, biology, pharmacology, and mathematical modeling to enable the prediction and analysis of drug behavior in the human body.
Furthermore, Certara provides expert consulting services that leverage their vast industry experience and scientific knowledge. Their team of consultants offers regulatory support, pharmacokinetic and pharmacodynamics modeling, clinical pharmacology, quantitative systems pharmacology, and drug safety expertise. These services help clients navigate the complex drug development and regulatory approval processes efficiently.
Certara's solutions and services are crucial throughout the entire drug development lifecycle. They aid in designing efficient clinical trials, optimizing dosing regimens, analyzing pharmacokinetic and pharmacodynamics data, interpreting and predicting drug-drug interactions, simulating virtual patient populations, and assessing drug safety.
Certara's contributions enable pharmaceutical companies to make better-informed decisions during drug development, which ultimately accelerates the delivery of safe and effective medicines to patients. Their innovative software tools and expert consulting services have helped numerous companies streamline their drug development processes, reduce costs, and enhance patient outcomes.